Health Novo Nordisk Shares Plunge as Heart Drug Trial Fails to Meet Key Goal August 1, 2026 Novo Nordisk faced a sharp selloff on Friday after the Danish pharmaceutical giant announced that its experimental heart drug ziltivekimab failed to achieve its primary goal in a late-stage clinical…